Granules India informs about press release

17 Dec 2024 Evaluate
Granules India has informed that it enclosed press release ‘Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the US’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

567.15 -6.80 (-1.18%)
20-Jan-2026 12:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.80
Dr. Reddys Lab 1185.50
Cipla 1379.40
Zydus Lifesciences 876.55
Lupin 2165.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×